Achondroplasia Treatment Market By Product type ( RBM-007, TA-46, B-701 ), By End-user ( Hospital, Clinics ), Industry Trends, Estimation & Forecast, 2017 - 2025

  • Published On: Apr, 2018
  • Category: Healthcare
  • Pages: 168
Achondroplasia Treatment Market is expected to grow with a CAGR of XX% during the forecast period of 2018 to 2025.

Market Overview:

Achondroplasia is a genetic disorder caused due to heredity or mutation of FGFR3 genes during sperm or egg development. It is also known as achondroplastic dwarfism as people suffering from it are abnormally short. Every 1 individual out of 25,000 births is affected by achondroplasia. At present, there is no prevention nor cure for achondroplastic dwarfism, due to which, the treatment is majorly focused on minimizing the complications such as sleep apnea, obesity, and arthritis. Research studies are focusing on the mutational changes occurring in the FGFR3 gene in order to identify the exact cause of achondroplasia and introduce a cure for it. The rising incidences of achondroplastic dwarfism with no cure or prevention remedies is expected to fuel the global market of achondroplasia treatment. Growth hormone therapy is an effective treatment for achondroplasia for only a short duration of time. The therapy has proved to be effective in growing the beneficial bones but only until the first and second year of the therapy. Such short duration effectiveness of GH therapy and the lack of awareness regarding achondroplastic dwarfism are expected to negatively influence the market growth. The report provides detailed qualitative and quantitative analysis of the global achondroplasia treatment market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely product type, and end-user in each of the major regions of the world.

Achondroplasia Treatment Market Segmentation

By Product Type • RBM-007 • TA-46 • B-701 • Others By End-user • Hospital • Clinic • Others By Geography • North America o U.S. o Canada o Mexico • Europe o U.K o France o Germany o Italy o Spain o Rest of Europe • Asia-Pacific o China o Japan o India o Korea o Rest of APAC • South America o Brazil o Rest of South America • Rest of the World o Middle East o Africa

CHAPTER 1. INTRODUCTION 1.1. RESEARCH METHODOLOGY 1.1.1. ERC desk research 1.1.2. ERC data synthesis 1.1.3. Data validation and market feedback 1.1.4. ERC data sources CHAPTER 2. ACHONDROPLASIA TREATMENT MARKET OVERVIEW 2.1. ACHONDROPLASIA TREATMENT MARKET INTRODUCTION 2.2. GLOBAL ACHONDROPLASIA TREATMENT MARKET PRODUCTION AND GROWTH RATE, 2017-2025 2.2.1. Global Achondroplasia Treatment Production (VOLUME) and Growth Rate (%), (2017-2025) 2.3. GLOBAL ACHONDROPLASIA TREATMENT MARKET CAPACITY AND GROWTH RATE, 2017-2025 2.3.1. Global Achondroplasia Treatment Capacity (VOLUME) and Growth Rate (%), (2017-2025) 2.4. GLOBAL ACHONDROPLASIA TREATMENT MARKET REVENUE AND GROWTH RATE, 2017-2025 2.4.1. Global Achondroplasia Treatment Market Revenue (Million USD) and Growth Rate (%), (2017-2025) 2.5. GLOBAL ACHONDROPLASIA TREATMENT MARKET CONSUMPTION AND GROWTH RATE, 2017-2025 2.5.1. Global Achondroplasia Treatment Consumption (VOLUME) and Growth Rate (%), (2017-2025) 2.6. GLOBAL ACHONDROPLASIA TREATMENT MARKET PRICE TREND, 2017-2025 2.6.1. Global Achondroplasia Treatment Market Price Trend and Growth Rate (%), (2017-2025) CHAPTER 3. GLOBAL ACHONDROPLASIA TREATMENT MARKET BY PRODUCT TYPE, 2017-2025 3.1. RBM-007 3.2. TA-46 3.3. B-701 3.4. GLOBAL ACHONDROPLASIA TREATMENT MARKET REVENUE BY PRODUCT TYPE, 2017-2025 3.4.1. Global Achondroplasia Treatment Market Revenue (Million USD) and Share (%) By Product type, 2017-2025 3.4.2. RBM-007 Market Revenue and Growth Rate, 2017-2025 3.4.3. TA-46 Market Revenue and Growth Rate, 2017-2025 3.4.4. B-701 Market Revenue and Growth Rate, 2017-2025 3.5. GLOBAL ACHONDROPLASIA TREATMENT MARKET PRODUCTION BY PRODUCT TYPE, 2017-2025 3.5.1. Global Achondroplasia Treatment Market Production (Volume) and Share (%) By Product type, 2017-2025 3.5.2. RBM-007 Market Production and Growth Rate, 2017-2025 3.5.3. TA-46 Market Production and Growth Rate, 2017-2025 3.5.4. B-701 Market Production and Growth Rate, 2017-2025 Note: Similar information coverage has been provided for other product type segment. CHAPTER 4. GLOBAL ACHONDROPLASIA TREATMENT MARKET BY END USER, 2017-2025 4.1. HOSPITAL 4.2. CLINIC 4.3. OTHERS 4.4. GLOBAL ACHONDROPLASIA TREATMENT MARKET REVENUE BY END USER, 2017-2025 4.4.1. Global Achondroplasia Treatment Market Revenue (Million USD) and Share (%) By End User, 2017-2025 4.4.2. Hospital Market Revenue and Growth Rate, 2017-2025 4.4.3. Clinic Market Revenue and Growth Rate, 2017-2025 4.4.4. Others Market Revenue and Growth Rate, 2017-2025 4.5. GLOBAL ACHONDROPLASIA TREATMENT MARKET CONSUMPTION BY END USER, 2017-2025 4.5.1. Global Achondroplasia Treatment Market Consumption (Volume) and share (%) By End User, 2017-2025 4.5.2. Hospital Market Consumption and Growth Rate, 2017-2025 4.5.3. Clinic Market Consumption and Growth Rate, 2017-2025 4.5.4. Others Market Consumption and Growth Rate, 2017-2025 CHAPTER 5. GLOBAL ACHONDROPLASIA TREATMENT MARKET BY REGION, 2017-2025 5.1. NORTH AMERICA 5.1.1. U.S. 5.1.2. Canada 5.1.3. Mexico 5.2. EUROPE 5.2.1. U.K. 5.2.2. France 5.2.3. Germany 5.2.4. Italy 5.2.5. Spain 5.2.6. Rest of Europe 5.3. ASIA PACIFIC 5.3.1. China 5.3.2. Japan 5.3.3. India 5.3.4. Korea 5.3.5. Rest of APAC 5.4. SOUTH AMERICA 5.4.1. Brazil 5.4.2. Rest of South America 5.5. REST OF THE WORLD 5.5.1. Middle East 5.5.2. Africa 5.6. GLOBAL ACHONDROPLASIA TREATMENT MARKET REVENUE BY REGION, 2017-2025 5.6.1. Global Achondroplasia Treatment Market Revenue (Million USD) and Share (%) By Region, 2017-2025 5.6.2. North America Market Revenue and Growth Rate, 2017-2025 5.6.3. Europe Market Revenue and Growth Rate, 2017-2025 5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025 5.6.5. South America Market Revenue and Growth Rate, 2017-2025 5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025 CHAPTER 6. GLOBAL ACHONDROPLASIA TREATMENT MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025 6.1. GLOBAL ACHONDROPLASIA TREATMENT MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025 6.1.1. Global Achondroplasia Treatment Market Production (Volume) and Share (%) By Region, 2017-2025 6.1.2. Global Achondroplasia Treatment Market Consumption (Volume) and Share (%) By Region, 2017-2025 6.1.3. North America Market Production and Consumption, 2017-2025 6.1.4. Europe Market Production and Consumption, 2017-2025 6.1.5. Asia Pacific Market Production and Consumption, 2017-2025 6.1.6. South America Market Production and Consumption, 2017-2025 6.1.7. Rest of the World Market Production and Consumption, 2017-2025 CHAPTER 7. MARKET DETERMINANTS 7.1. MARKET DRIVERS 7.2. MARKET RESTRAINTS 7.3. MARKET OPPORTUNITIES 7.4. MARKET DETERMINANTS RADAR CHART CHAPTER 8. GLOBAL ACHONDROPLASIA TREATMENT MARKET COMPETITION BY MANUFACTURERS 8.1. GLOBAL ACHONDROPLASIA TREATMENT PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025) 8.1.1. Global Achondroplasia Treatment Production (VOLUME) and Share (%) by Manufacturers (2017-2025) 8.2. GLOBAL ACHONDROPLASIA TREATMENT REVENUE AND SHARE BY MANUFACTURERS (2017-2025) 8.2.1. Global Achondroplasia Treatment Revenue (Million USD) and Share (%) by Manufacturers (2017-2025) 8.3. ACHONDROPLASIA TREATMENT MARKET COMPETITIVE SITUATION AND TRENDS 8.3.1. Achondroplasia Treatment Market Share (%) of Top 3 Manufacturers 8.3.2. Achondroplasia Treatment Market Share (%) of Top 5 Manufacturers CHAPTER 9. GLOBAL ACHONDROPLASIA TREATMENT MANUFACTURERS ANALYSIS 9.1. ASCENDIS PHARMA A/S 9.1.1. Business Overview 9.1.2. Company Basic Information 9.1.3. Achondroplasia Treatment Product Details 9.1.4. Ascendis Pharma A/S Achondroplasia Treatment Production, Revenue and Gross Margin 9.2. RIBOMIC INC 9.2.1. Business Overview 9.2.2. Company Basic Information 9.2.3. Achondroplasia Treatment Product Details 9.2.4. Ribomic Inc Achondroplasia Treatment Production, Revenue and Gross Margin 9.3. BIOMARIN PHARMACEUTICAL INC 9.3.1. Business Overview 9.3.2. Company Basic Information 9.3.3. Achondroplasia Treatment Product Details 9.3.4. BioMarin Pharmaceutical Inc Achondroplasia Treatment Production, Revenue and Gross Margin CHAPTER 10. ACHONDROPLASIA TREATMENT MARKET VALUE CHAIN ANALYSIS 10.1. ACHONDROPLASIA TREATMENT INDUSTRIAL CHAIN ANALYSIS 10.2. ACHONDROPLASIA TREATMENT KEY RAW MATERIALS ANALYSIS 10.2.1. Key Raw Materials 10.2.2. Price Trend of Key Raw Materials 10.2.3. Key Suppliers of Raw Materials 10.3. MARKETING CHANNEL 10.3.1. Direct Marketing 10.3.2. Indirect Marketing 10.3.3. Distributors/Traders 10.4. CONSUMER ANALYSIS 10.4.1. Consumer 1 10.4.2. Consumer 2 10.4.3. Consumer 3 10.4.4. Consumer 4

• Ribomic Inc
• Ascendis Pharma A/S
• BioMarin Pharmaceutical Inc

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS